Entry Detail



General Information

Database ID:exR0091866
RNA Name:hsa-miR-302a-3p
RNA Type:miRNA
Chromosome:chr4
Starnd:-
Coordinate:
Start Site(bp):112648186End Site(bp):112648208
External Links:hsa-miR-302a-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ZBTB5
chr9
37438102
37465450
-
PPP1R8
chr1
27830782
27851676
+
ATP6V1C1
chr8
103021063
103073051
+
SEC23B
chr20
18507520
18561415
+
FABP5
chr8
81280536
81284777
+
THRAP3
chr1
36224432
36305357
+
LONP2
chr16
48244300
48363122
+
KLC1
chr14
103561896
103714249
+
FAM222B
chr17
28755978
28855232
-
WASF3
chr13
26557683
26688948
+
TOP2A
chr17
40388525
40417896
-
APP
chr21
25880550
26171128
-
ARL4A
chr7
12686856
12690958
+
PDRG1
chr20
31944337
31952046
-
SCAMP2
chr15
74843730
74873365
-
RAB31
chr18
9708275
9862551
+
IKZF4
chr12
56007659
56038435
+
RACGAP1
chr12
49976923
50033136
-
MGLL
chr3
127689062
128052190
-
HABP4
chr9
96450169
96491336
+
USP6NL
chr10
11453946
11611754
-
RGMA
chr15
93035273
93089204
-
JARID2
chr6
15246069
15522042
+
BAZ1B
chr7
73440406
73522293
-
CLIP4
chr2
29097705
29189643
+
IPO7
chr11
9384652
9448127
+
SEC23IP
chr10
119892730
119944657
+
VLDLR
chr9
2621787
2660056
+
IZUMO2
chr19
50152548
50163195
-
SSR1
chr6
7268306
7347446
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC011503.2
chr19
23927788
23929287
+
AC125257.1
chr17
41848518
41851447
-
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.